The KIF5A gene gives nerve cells instructions for a motor protein that carries important cargo along their long internal tracks. If this gene does not work properly, those cells may struggle to move supplies where they are needed, which can affect muscle control, walking, hand use, and speech or swallowing. Pathogenic variants in the KIF5A gene are linked to inherited nerve conditions including hereditary spastic paraplegia, some forms of Charcot-Marie-Tooth disease, and, in some families, amyotrophic lateral sclerosis.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or guide activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. In combination, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. To go into more detail on this subject, you can read more in the LearnHub.
Overview
KIF5AGene function
What if the gene works
The KIF5A gene helps nerve cells move supplies along their internal tracks, especially down long fibers. This supports everyday signaling and helps keep the ends of nerves working.
Risk
What if the gene does not work
Variants in the KIF5A gene can affect nerve cells and are linked to inherited movement and nerve conditions, including leg stiffness and weakness, peripheral neuropathy, and some forms of ALS. Milder to more severe variants may influence onset and symptoms.
Treatment
What does that mean for your treatment
For pathogenic variants in the KIF5A gene, no gene-specific treatment or drug selection approach is currently established in clinical guidelines. The KIF5A gene is being studied in amyotrophic lateral sclerosis and other nerve conditions as a possible treatment target, but this has not yet changed standard care.
Conditions associated with KIF5A
Gene function
What if the gene works
The KIF5A gene helps nerve cells move essential materials from the cell body out to distant parts of the cell. This steady transport is especially important in long nerves, where supplies must travel over large distances. Understanding how the KIF5A gene helps nerve cells send signals makes its day-to-day role easier to picture.
The KIF5A gene makes part of a motor protein that carries cell cargo along microtubules (the cell’s internal tracks). In nerve cells, this helps mitochondria, vesicles, and other supplies reach the places where they are needed.
Long nerve fibers need a steady flow of proteins, membranes, and other parts. KIF5A helps deliver these materials from the cell body toward the axon and nerve ending.
Nerve cells work best when energy sources and communication packages are in the right place. By moving these cargoes to key areas, KIF5A supports everyday nerve signaling and routine cell maintenance.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or the body’s response to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
KIF5A variants can change how the protein folds, moves on tracks, or attaches to cargo in nerve cells, showing how KIF5A gene variants affect protein function. Some missense variants in the motor region reduce movement, while tail region variants can disrupt splicing (how RNA is pieced together) and create an abnormal protein that tends to clump. Milder changes may partly lower transport, while more disruptive variants can have stronger effects and may be linked to earlier or widespread neurologic features.
How variants are linked to conditions
Variants in the KIF5A gene are linked to several inherited nerve conditions. The best established KIF5A gene variants linked to conditions include hereditary spastic paraplegia type 10, some forms of Charcot-Marie-Tooth disease, and amyotrophic lateral sclerosis (ALS). Different variants are associated with different patterns of symptoms, so a change in this gene does not point to the same diagnosis in every person.
A variant is not necessarily a diagnosis
DNA variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that clearly increase or reduce health risks linked to the KIF5A gene. For many living with a disease-causing KIF5A change, the main driver of risk is the genetic variant itself, while symptoms and severity can still vary from one family member to another.
Inheritance of KIF5A variants
KIF5A-related conditions are usually inherited in an autosomal dominant pattern. In practical terms, how KIF5A gene variants are inherited means that a parent with a disease-causing variant in the KIF5A gene can pass it to a son or daughter, and each child has a 1 in 2, or 50%, chance of inheriting that variant. A person who inherits the variant may or may not have the same features or severity as their parent.
What does my KIF5A result mean for my family?
For many KIF5A-related conditions, the gene change is passed on in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same result and may want to learn whether it applies to them. In a family, this can mean similar nerve or movement problems show up in more than one generation, although symptoms can differ from person to person.
Genetic information
Genetic testing
How you find out about variants
To find out about variants in the KIF5A gene, genetic testing looks at your DNA from a blood sample, saliva, or cheek swab. Genetic testing for KIF5A variants may be done as a single gene test or a panel, and the lab reads the KIF5A gene’s code to look for changes that can help explain symptoms or confirm a diagnosis.
When should I consider getting a genetic test?
If you or close relatives have a family pattern of progressive leg stiffness, trouble walking, muscle weakness, nerve problems in the feet or hands, or ALS, testing the KIF5A gene may help explain the cause. It can also help clarify whether the condition could run in the family.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies by the condition and the specific type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than others, which can change how much of the medicine reaches the body and brain over time. This is a common reason why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It studies gene and drug patterns to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed and more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the KIF5A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing. If you have side effects, questions about a new medicine, or changes in your health, talk with your doctor or pharmacist.
History
KIF5A entered the genetics literature through studies of inherited nerve conditions that affected movement in families. Initially understood only through visible traits, later recognized as tied to a specific gene, it was linked in 2010 to some forms of hereditary spastic paraplegia and Charcot-Marie-Tooth disease type 2. That finding helped connect earlier family patterns with a shared genetic cause. From these first observations, research expanded steadily. In 2018, large genetic studies also identified variants in the KIF5A gene in some people with amyotrophic lateral sclerosis, broadening medical interest in the gene. This history marked an important step in showing how one gene can be involved in different neurological conditions.